Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 396-399

  Yamamoto, Miyuki ^b   Nakama, Hidenori ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Colorectal cancer screening; Cost effectiveness; Immunochemical fecal occult blood test

Indexed keywords

ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOCHEMISTRY; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; SAMPLING;

ADULT; AGED; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS;

EID: 0034003279     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. 1 Mandel JS, Bond JH, Church TR, et al: Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328:1365-1371.
2. 2 Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996 348:1467-71.
3. 3 Hardcastle JD, Chamberlain JO, Robinson MHE, et al: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348:1472-1477.
4. 4 Nakama H: A study on the efficacy of a screening program for colorectal cancer in a small Japanese village. Clin Investig 1994; 72:117-121.
5. 5 Saito H, Soma Y, Koeda J, et al: Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995; 61:465-469.
6. 6 Iida Y, Munemoto Y, Miura S, et al: Clinicopathologic studies of immunologic fecal occult blood test for colorectal cancer. J Gastroenterol 1995; 30:195-200.
7. 7 Nakama H, Kamijo N: Accuracy of the immunological fecal occult blood testing for colorectal cancer screening. Prev Med 1994; 23:309-313.
8. 8 Nakama H, Kamijo N, Fattah ASMA, Zhang B: Validity of immunological faecal occult blood screening for colorectal cancer screening: a follow up study. J Med Screen 1996; 3:63-65.
9. 9 Itoh M, Takahashi K, Nishida H, Sakagami K, Okubo T: Estimation of the optimal cut off point in a new immunological faecal occult test in a corporate colorectal cancer screening programme. J Med Screen 1966; 3:66-71.
10. 10 Allison JE, Tekawa IS, Ranson LJ, et al: A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996; 334:155-159.
11. 11 Simon JB: Occult blood screening for colorectal cancer: a critical review. Gastroenterology 1985; 88:820-837.
12. 12 Rogge JD, Elmore MF, Mahoney SJ, et al: Low-cost, office-based, screening colonoscopy. Am J Gastroenterol 1994; 89:1775-1780.
13. 13 Lieberman DA: Cost-effectiveness model for colon cancer screening. Gastroenterology 1995; 109:1781-1790.
14. 14 Provenzale D, Lipscomb J: A reader's guide to economic analysis in the GI literature. Am J Gastroenterol 1996; 91:2461-2470.
15. 15 Schwartz S, Ellefson M: Quantitative fecal recovery of ingested hemoglobin-hem in blood: comparisons by Hem-Quant assay with ingested meat and fish. Gastroenterology 1985; 89:19-26.
16. 16 Yoshida Y, Saito H, Tsuchida S, et al: A simple sensitive immunologic fecal occult blood test suitable for mass screening for colorectal cancer. Gastroenterology 1986; 90:1699. (Abstract)
17. 17 Saito H, Yoshida Y: Mass screening - Japanese perspective. In: Young GP, Rosen P, Levine B (Eds.). Prevention and early detection of colorectal cancer: Principles and practice. London: WB Saunders, 1996; pp. 301-311.
18. 18 Tsuji I, Fukao A, Shoji T, Kuwajima I, Sugawara N, Hisamichi S: Cost-effectiveness analysis of screening for colorectal cancer in Japan. Tohoku J Exp Med 1991; 164:269-278.
19. 19 Shimbo T, Glick HA, Eisenberg JM: Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan. Int J Technol Assess Health Care 1994; 10:359-375.